We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

1 hedge funds and large institutions have $204K invested in BioSpecifics Technologies Corp. in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 112 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 112

99% less funds holding

Funds holding: 113 → 1 (-112)

100% less capital invested

Capital invested by funds: $254M → $204K (-$254M)

Holders
1
Holders Change
-112
Holders Change %
-99.12%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
112
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
+$184K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$29.9M
2
BlackRock
BlackRock
New York
-$23.8M
3
RHJA
Rice Hall James & Associates
California
-$19.5M
4
Russell Investments Group
Russell Investments Group
United Kingdom
-$17.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$16.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
76
IndexIQ Advisors
New York
– -$175K -3,320 Closed
MIM
77
MetLife Investment Management
New Jersey
– -$160K -3,035 Closed
UBS Group
78
UBS Group
Switzerland
– -$159K -3,005 Closed
MF
79
Manchester Financial
California
– -$156K -2,954 Closed
Barclays
80
Barclays
United Kingdom
– -$151K -2,850 Closed
CL
81
CIM LLC
New York
– -$237K -2,680 Closed
GC
82
Globeflex Capital
California
– -$127K -2,402 Closed
Bank of America
83
Bank of America
North Carolina
– -$116K -2,208 Closed
MLICM
84
Metropolitan Life Insurance Company (MetLife)
New York
– -$111K -2,100 Closed
MAM
85
Meeder Asset Management
Ohio
– -$86K -1,627 Closed
BNP Paribas Financial Markets
86
BNP Paribas Financial Markets
France
– -$77.3K -1,464 Closed
Morgan Stanley
87
Morgan Stanley
New York
– -$72K -1,378 Closed
Nisa Investment Advisors
88
Nisa Investment Advisors
Missouri
– -$72K -1,354 Closed
CAPTRUST Financial Advisors
89
CAPTRUST Financial Advisors
North Carolina
– -$69K -1,295 Closed
APA
90
American Portfolios Advisors
New York
– -$56.8K -1,076 Closed
Legal & General Group
91
Legal & General Group
United Kingdom
– -$53K -998 Closed
EA
92
Emerald Advisers
Pennsylvania
– -$48K -900 Closed
PAM
93
Panagora Asset Management
Massachusetts
– -$42K -796 Closed
ASN
94
Advisory Services Network
Georgia
– -$41K -775 Closed
Acadian Asset Management
95
Acadian Asset Management
Massachusetts
– -$39K -739 Closed
GT
96
Glenmede Trust
Pennsylvania
– -$34K -648 Closed
US Bancorp
97
US Bancorp
Minnesota
– -$31K -594 Closed
AIP
98
Ameritas Investment Partners
Nebraska
– -$26K -496 Closed
Canada Life
99
Canada Life
Manitoba, Canada
– -$26K -489 Closed
Macquarie Group
100
Macquarie Group
Australia
– -$23K -440 Closed
1 2 3
4
5

BSTC Hedge Fund Activity: Q4 2020 in Review

1 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2020, worth a combined $204K — down 100% from $254M a quarter earlier.

Sellers outnumbered buyers: 112 funds closed out of BSTC and 1 opened new positions — a net loss of 111 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was UBS AM, opening a new position worth an estimated $184K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $29.9M sold.

  • 1 institutional investor held BioSpecifics Technologies Corp. (BSTC) as of Q4 2020, down from 113 in Q3 2020.
  • Funds reported $204K of BioSpecifics Technologies Corp. stock for Q4 2020, down 100% quarter-over-quarter.
  • 1 fund opened new BioSpecifics Technologies Corp. positions in Q4 2020 and 112 closed out, a net change of -111 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2020 was UBS AM, an estimated $184K added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2020 was Renaissance Technologies, an estimated $29.9M sold.

Based on aggregated 13F filings for Q4 2020.